Trials / Completed
CompletedNCT04672447
Effect of 4 Weeks of Citrulline and Glutathione Supplementation on Arterial Function
Effects of 4 Weeks Supplementation With L-Citrulline and Glutathione on Arterial Function and Cardiovascular Responses in Postmenopausal Healthy Women: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Texas Tech University · Academic / Other
- Sex
- Female
- Age
- 50 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
Examining the effects of 4 weeks of Citrulline alone or in combination with glutathione on the arterial function of postmenopausal women.
Detailed description
L-Citrulline is a non-protein amino acid and an efficient precursor of L-arginine, the substrate for endothelial nitric oxide synthesis. Glutathione is a tripeptide with antioxidant effects. Postmenopausal women will ingest 6g/d of L-Citrulline or 2g of L-Citrulline plus 200mg/d of glutathione or placebo (maltodextrin) for 4 weeks with vascular function testing prior to and after the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | L-Citrulline | Four weeks of oral L-Citrulline (2 grams/day) supplementation. Supplementation will be ingested daily, half of the doses in the morning and half at night. |
| DIETARY_SUPPLEMENT | L-Citrulline | Four weeks of oral L-Citrulline (6 grams/day) supplementation. Supplementation will be ingested daily, half of the doses in the morning and half at night. |
| DIETARY_SUPPLEMENT | Placebo | Four weeks of oral placebo (6 grams/day maltodextrin) supplementation. Supplementation will be ingested daily, half of the doses in the morning and half at night. |
| DIETARY_SUPPLEMENT | Glutathione | Four weeks of Glutathione (200mg/day) supplementation. Supplementation will be ingested daily, half of the doses in the morning and half at night. |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2022-04-27
- Completion
- 2022-04-27
- First posted
- 2020-12-17
- Last updated
- 2022-10-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04672447. Inclusion in this directory is not an endorsement.